Mirpharm

Mirpharm is an international group of pharmaceutical companies with its own R&D centers and manufacturing facilities in Russia and the European Union. With a commitment to full-cycle pharmaceutical development, Mirpharm actively participates in projects that cover everything from synthesizing active pharmaceutical ingredients to bringing finished medications to market. The company prides itself on its transparency and responsibility, ensuring that its manufacturing practices do not harm the environment or public health.

With over 25 years of continuous development, Mirpharm produces more than 20 tons of pharmaceutical substances annually and manages a portfolio of over 100 medications in various stages of development. Their product range includes treatments for numerous therapeutic areas such as cardiology, oncology, neurology, and gastroenterology. Dedicated to enhancing patient access to innovative therapies, Mirpharm focuses on unique products tailored for the Russian market while upholding high standards of quality and safety in pharmaceutical manufacturing.